Catalyst Wire Dossier Catalyst Wire Dossier

LEO 138559

· LEO Pharma
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for LEO 138559, covering 2023-07-24 to 2026-02-12. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis [Phase 2]

See pricing